|
What is Paxil®? Paxil® – which is a trade-name of Paroxetine - is a type of medication classed as a Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant, and was released in 1992 by the pharmaceutical company GlaxoSmithKline. Paxil® medication has been used to treat depression, obsessive-compulsive conditions, panic-attacks, and anxiety-based disorders, and was the first antidepressant to formally receive approval in the U.S. for the specific treatment of panic-attacks. Paxil® medication is designed to balance the patient’s levels of serotonin - a naturally-occurring substance in the brain that assists in improving and regulating mood. Medication and Side-Effects On July 19, 2006, the Food and Drug Administration (FDA) detailed the conclusions of two studies that described adverse side-effects in some patients prescribed the medication Paxil®. First, the FDA outlined the findings of a study that was published in February 2006 in the Journal of the American Medical Association (JAMA). The authors of the study focused their attention on the experiences of a group of pregnant women who had previously suffered from major depression. During the period of their pregnancies, some of the women who were no longer feeling depressed stopped taking their antidepressant medicines. Others, however, decided to remain on their antidepressants. The study demonstrated that those patients who ceased taking their medicine while pregnant were five times more likely to have a relapse of depression than were those that continued to take their antidepressant medicine during pregnancy. The second study referred to by the FDA – that appeared on February 9, 2006 in the New England Journal of Medicine – was focused on reports of newborn babies suffering from Persistent Pulmonary Hypertension of the Newborn (PPHN), which can be described as a serious and life-threatening condition of the lungs. Babies born with PPHN experience high-pressure in the blood vessels of their lungs; and, therefore, are not able to get adequate amounts of oxygen into their bloodstream. According to the New England Journal of Medicine study, PPHN was six times more prevalent in babies whose mothers took an SSRI antidepressant after the 20th week pregnancy when compared with babies whose mothers did not take antidepressants. Contact Us If you or a loved one has suffered from serious, life-threatening conditions that may have resulted from taking the medication Paxil®, contact DrugRxRecall immediately. After you contact us, we will be very pleased to refer you to a skilled, highly motivated and experienced lawyer who can offer you a free consultation on potential claims for accidents, injuries and deaths that may have been caused by the side-effects of the medication Paxil®.
|
